These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2952710

  • 21. CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.
    Starling GC, Hart DN.
    Immunology; 1990 Oct; 71(2):190-5. PubMed ID: 2146214
    [Abstract] [Full Text] [Related]

  • 22. T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.
    Fast LD, Beatty P, Hansen JA, Newman W.
    J Immunol; 1983 Nov; 131(5):2404-10. PubMed ID: 6415167
    [Abstract] [Full Text] [Related]

  • 23. CR2 ligands modulate human B cell activation.
    Bohnsack JF, Cooper NR.
    J Immunol; 1988 Oct 15; 141(8):2569-76. PubMed ID: 2459218
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S, Giudizi MG, Biagiotti R, Almerigogna F, Maggi E, Del Prete G, Ricci M.
    J Immunol; 1981 Oct 15; 127(4):1307-13. PubMed ID: 6974188
    [Abstract] [Full Text] [Related]

  • 26. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
    Kuwano K, Arai S, Munakata T, Tomita Y, Yoshitake Y, Kumagai K.
    J Immunol; 1986 Sep 01; 137(5):1462-8. PubMed ID: 3018077
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity.
    Seaman WE, Talal N, Herzenberg LA, Herzenberg LA, Ledbetter JA.
    J Immunol; 1981 Sep 01; 127(3):982-6. PubMed ID: 6790624
    [Abstract] [Full Text] [Related]

  • 29. Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells.
    Dennis G, June CH, Mizuguchi J, Ohara J, Witherspoon K, Finkelman FD, McMillan V, Mond JJ.
    J Immunol; 1987 Oct 15; 139(8):2516-23. PubMed ID: 2821117
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
    Yamashita T, Koyama J.
    J Immunol; 1988 Nov 01; 141(9):2889-94. PubMed ID: 2971734
    [Abstract] [Full Text] [Related]

  • 31. Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2.
    Jamin C, Le Corre R, Lydyard PM, Youinou P.
    Eur J Immunol; 1996 Jan 01; 26(1):57-62. PubMed ID: 8566084
    [Abstract] [Full Text] [Related]

  • 32. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T, Butler JL, Cooper MD.
    J Immunol; 1985 Apr 01; 134(4):2470-6. PubMed ID: 2982946
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Poly-N-acetyllactosamine structures on murine cell surface T200 glycoprotein participate in natural killer cell binding to YAC-1 targets.
    Gilbert CW, Zaroukian MH, Esselman WJ.
    J Immunol; 1988 Apr 15; 140(8):2821-8. PubMed ID: 2965731
    [Abstract] [Full Text] [Related]

  • 35. Regulation of human B cell activation and antibody production by non-major histocompatibility complex-restricted cytotoxic T lymphocytes.
    Boué F, Goujard C, Delfraissy JF, Galanaud P, Hercend T.
    Eur J Immunol; 1989 Mar 15; 19(3):529-35. PubMed ID: 2785047
    [Abstract] [Full Text] [Related]

  • 36. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.
    Storkus WJ, Dawson JR.
    J Immunol; 1986 Mar 01; 136(5):1542-7. PubMed ID: 3081629
    [Abstract] [Full Text] [Related]

  • 37. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 38. Developmental sequence of T200 antigen modifications in murine T cells.
    Lefrancois L, Goodman T.
    J Immunol; 1987 Dec 01; 139(11):3718-24. PubMed ID: 2960741
    [Abstract] [Full Text] [Related]

  • 39. The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen.
    Lipsky PE, Thompson PA, Rosenwasser LJ, Dinarello CA.
    J Immunol; 1983 Jun 01; 130(6):2708-14. PubMed ID: 6222114
    [Abstract] [Full Text] [Related]

  • 40. Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation.
    Koyama N, Harada N, Takahashi T, Mita S, Okamura H, Tominaga A, Takatsu K.
    Immunology; 1988 Feb 01; 63(2):277-83. PubMed ID: 3280472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.